Identification of human NK17/NK1 cells

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Pandya, Abhilash D ^a   Al Jaderi, Zaidoon ^a   Høglund, Rune A ^a   Holmøy, Trygve ^b   Harbo, Hanne F ^b   Norgauer, Johannes ^c   Maghazachi, Azzam A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 21; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; IONOMYCIN; MACROPHAGE DERIVED CHEMOKINE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA1; INTERLEUKIN 1;

ARTICLE; CELL ISOLATION; CELL POLARITY; CELL SECRETION; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE SCLEROSIS; NATURAL KILLER 1 CELL; NATURAL KILLER 17 CELL; NATURAL KILLER CELL; PROTEIN EXPRESSION; TH1 CELL; TH17 CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1; INTERLEUKIN-17; KILLER CELLS, NATURAL; MULTIPLE SCLEROSIS;

EID: 80054830970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026780     Document Type: Article

References (28)

1. Lodoen MB, Lanier LL, (2006) Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18: 391-398.
2. Robertson MJ, Ritz J, (1990) Biology and clinical relevance of human natural killer cells. Blood 76: 2421-2438.
3. Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, et al. (1998) Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 161: 5821-5824.
4. Berahovich RD, Lai NL, Wei Z, Lanier LL, Schall TJ, (2006) Evidence for NK cell subsets based on chemokine receptor expression. J Immunol 177: 7833-7840.
5. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, et al. (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725.
6. Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, et al. (2009) Human fetal lymphoid tissue-inducer cells are interleukin 17 producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 10: 66-74.
7. Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, et al. (2009) RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 10: 83-91.
8. Hughes T, Becknell B, McClory S, Briercheck E, Freud AG, et al. (2009) Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH17 cytokine interleukin-22. Blood 113: 4008-4010.
9. Shi FD, Zhou Q, (2011) Natural killer cells as indispensable players and therapeutic targets in autoimmunity. Autoimmunity 44: 3-10.
10. Maghazachi AA, (2010) Role of chemokines in the biology of natural killer cells. Curr Topics Microbiol Immunol 341: 37-58.
11. Sand KL, Rolin J, Knudsen E, Al-Falahi Y, Maghazachi AA, (2009) Modulation of natural killer cell cytotoxicity and cytokine release by the drug glatiramer acetate. Cell Mol Life Sci 66: 1446-1456.
12. Rolin J, Sand KL, Knudsen E, Maghazachi AA, (2010) FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release. Cancer Immunol Immnuother 59: 575-586.
13. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, et al. (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381.
14. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S, (2008) The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int Immunol 20: 1361-1368.
15. Inngjerdingen M, Damaj B, Maghazachi AA, (2000) Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J Immunol 164: 4048-4054.
16. Maghazachi AA, (1997) Role of the heterotrimeric G proteins in stromal-derived factor-1α-induced natural killer cell chemotaxis and calcium mobilization. Biochem Biophys Res Commun 236: 270-274.
17. Bernardini G, Sciumè G, Bosisio D, Morrone S, Sozzani S, et al. (2008) CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood 111: 3626-3634.
18. Al-Aoukaty A, Rolstad B, Giaid A, Maghazachi AA, (1998) MIP-3α, MIP-3β and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells. Immunology 95: 618-624.
19. Robertson MJ, Williams BT, Christopherson K 2nd, Brahmi Z, Hromas R, (2000) Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines. Cell Immunol. 199: 8-14.
20. Inngjerdingen M, Damaj B, Maghazachi AA, (2001) Expression and regulation of.
21. chemokine receptors in human natural killer cells. Blood 97: 367-375.
22. Moretta L, Locatelli F, Pende D, Marcenaro E, Mingari MC, et al. (2011) Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood 117: 764-71.
23. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, et al. (2006) The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
24. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
25. Al-Falahi Y, Sand KL, Knudsen E, Damaj BB, Rolin J, et al. (2009) Splenic natural killer cell activity in two models of experimental neurodegenerative diseases. J Cell Mol Med 13: 2693-2703.
26. Cooper MA, Colonna M, Yokoyama WM, (2009) Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Reports 10: 1103-1110.
27. Hao J, Liu R, Piao W, Zhou Q, Vollmer TL, et al. (2010) Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med 207: 1907-1921.
28. Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, et al. (2006) Regulatory CD56bright natural killer cells mediate immunoregulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci USA 103: 5941-5946.